NASDAQ:REGN · Health Technology
Regeneron Pharmaceuticals, Inc.
$678.94▲ +0.3%Prices by TradingView · at least 15 min delayed
- Market cap
- $71.2B
- P/E (TTM)
- 16.5
- Dividend yield
- 0.56%
- 1y performance
- +23.4%
- YTD performance
- -12.3%
- 52-week range
- $541.00 – $821.11
- Currency
- USD
- Exchange
- NASDAQ
Held by these funds
issuer-published weights · 5 covered fundsFundWeight
iShares Core S&P 500 (USD)0.10%iShares Core S&P 500 UCITS ETF ETFS0.10%iShs-MSCI World UCITS ETF Registered Shares USD (Dist)oN0.08%iShares Core MSCI World UCITS ETFS0.08%iShares MSCI ACWI0.07%Prices by TradingView, at least 15 minutes delayed. Fund weights are issuer-published. This is information, not advice.